Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA; TAX 327 Investigators. Tannock IF, et al. Among authors: turesson i. N Engl J Med. 2004 Oct 7;351(15):1502-12. doi: 10.1056/NEJMoa040720. N Engl J Med. 2004. PMID: 15470213 Free article. Clinical Trial.
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.
Fitzpatrick JM, Anderson J, Sternberg CN, Fleshner N, Fizazi K, Rébillard X, Dogliotti L, Conti G, Turesson I, James N, Heidenreich A, Solsona E, Guillem V, Herchenhorn D, Moul J, van Moorselaar J, Coetzee LJ, Wilson A, Bamias A, De Wit R, Chrisofos M. Fitzpatrick JM, et al. Among authors: turesson i. Crit Rev Oncol Hematol. 2008 Oct;68 Suppl 1:S9-S22. doi: 10.1016/j.critrevonc.2008.07.019. Epub 2008 Aug 23. Crit Rev Oncol Hematol. 2008. PMID: 18723368 Review.
Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
Jebsen NL, Bruland ØS, Eriksson M, Engellau J, Turesson I, Folin A, Trovik CS, Hall KS. Jebsen NL, et al. Among authors: turesson i. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1359-66. doi: 10.1016/j.ijrobp.2010.07.037. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20933339
Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: a randomized controlled trial in prostate cancer patients undergoing radiotherapy.
Pettersson A, Johansson B, Persson C, Berglund A, Turesson I. Pettersson A, et al. Among authors: turesson i. Radiother Oncol. 2012 Jun;103(3):333-40. doi: 10.1016/j.radonc.2012.04.006. Epub 2012 May 24. Radiother Oncol. 2012. PMID: 22633817 Clinical Trial.
Low-dose hypersensitivity: current status and possible mechanisms.
Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Joiner MC, et al. Among authors: turesson i. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):379-89. doi: 10.1016/s0360-3016(00)01471-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173131 Review.
292 results